Last edition
News about "rare endocrine diseases"
Vertex Completes Acquisition of Crinetics Pharmaceuticals
Vertex completes its acquisition of Crinetics Pharmaceuticals on September 1, 2026, expanding its portfolio and executive leadership team.
Rare Endocrine Diseases | 04/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members